# An In Silico Transwell Device for the Study of Drug Transport and Drug–Drug Interactions

- 188 Downloads
- 9 Citations

## Abstract

### Purpose

Validate and exemplify a discrete, componentized, in silico, transwell device (ISTD) capable of mimicking the *in vitro* passive transport properties of compounds through cell monolayers. Verify its use for studying drug–drug interactions.

### Methods

We used the synthetic modeling method. Specialized software components represented spatial and functional features including cell components, semi-porous tight junctions, and metabolizing enzymes. Mobile components represented drugs. Experiments were conducted and analyzed as done *in vitro*.

### Results

Verification experiments provided data analogous to those in the literature. ISTD parameters were tuned to simulate and match *in vitro* urea transport data; the objects representing tight junction (effective radius of 6.66 Å) occupied 0.066% of the surface area. That ISTD was then tuned to simulate pH-dependent, *in vitro* alfentanil transport properties. The resulting ISTD predicted the passive transport properties of 14 additional compounds, individually and all together in one in silico experiment. The function of a two-site enzymatic component was cross-validated with a kinetic model and then experimentally validated against *in vitro* benzyloxyresorufin metabolism data. Those components were used to exemplify drug–drug interaction studies.

### Conclusions

The ISTD is an example of a new class of simulation models capable of realistically representing complex drug transport and drug–drug interaction phenomena.

### Key words

agent-based modeling discrete event drug transport drug–drug interaction emergent properties simulation### Abbreviations

- CYP
a P450 enzyme

- ISTD
in silico transwell device

- MW
molecular weight

- PCP
physicochemical properties

- PRN
pseudorandom number

- SM
supplementary material

- TD
transwell device

## Notes

### Acknowledgment

This research was funded in part by grant R21CDH00101 from the CDH Research Foundation (of which CAH is a trustee). We thank Professors John Verboncoeur and George Sensabaugh for encouragement. We thank the members of Biosystems Group for helpful discussions, with special thanks going Teddy Lam, Sean Kim, Mark Grant, and Li Yan for commentary on the manuscript, to Sunwoo Park for technical support, and Glen Ropella for his support and keen technical and theoretical insights.

## Supplementary material

### References

- 1.Y. Liu and C. A. Hunt. Studies of intestinal drug transport using an in silico epithelio-mimetic device.
*Biosystems***82**:154–167 (2005).PubMedCrossRefGoogle Scholar - 2.Y. Liu and C. A. Hunt. Mechanistic study of the cellular interplay of transport and metabolism using the synthetic modeling method.
*Pharm. Res.***23**:493–505 (2006).PubMedCrossRefGoogle Scholar - 3.G. E. Ropella, C. A. Hunt, and D. A. Nag. Using heuristic models to bridge the gap between analytic and experimental models in biology. In L. Yilmaz (ed),
*Agent-Directed Simulation Symposium*, Vol. Simulation Series 37(2) (ADS’05). SCS Press, San Diego, CA, 2005, pp. 182–190.Google Scholar - 4.G. E. P. Ropella, C. A. Hunt, and S. Sheikh-Bahaei. Methodological considerations of heuristic modeling of biological systems.
*9th World Multi-Conference on Systemics, Cybernetics and Informatics*, Orlando, FL, 2005.Google Scholar - 5.C. A. Hunt, G. E. Ropella, L. Yan, D. Y. Hung, and M. S. Roberts. Physiologically based synthetic models of hepatic disposition.
*J. Pharmacokinet. Pharmacodyn.***33**:737–772 (2006).PubMedCrossRefGoogle Scholar - 6.S. Sheikh-Bahaei and C. A. Hunt. Prediction of
*in vitro*hepatic biliary excretion using stochastic agent-based modeling and fuzzy clustering. In: L. F. Perrone*et al*. (eds.),*Proc. of the 37th Conference**on**Winter Simulation,*1617–24 (2006).Google Scholar - 7.S. Railsback et al. Agent-based simulation platforms: review and development recommendations.
*Simulation***82**:609–623 (2006).CrossRefGoogle Scholar - 8.G. T. Knipp, N. F. Ho, C. L. Barsuhn, and R. T. Borchardt. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size.
*J. Pharm. Sci.***86**:1105–1110 (1997).PubMedCrossRefGoogle Scholar - 9.R. Hine. Membrane,
*The Facts on File Dictionary of Biology*, Checkmark, New York, 1999, pp. 198.Google Scholar - 10.P. Ball. Introduction to discrete event simulation,
*2nd DYCOMANS workshop on "Management and Control: Tools in Action,”*Algarve, Portugal, 1996, pp. 367–76.Google Scholar - 11.T. H. Cormen, C. E. Leiserson, and R. L. Rivest.
*Introduction to algorithms*, McGraw-Hill, New York, 1990.Google Scholar - 12.G. Camenisch, G. Folkers, and H. van de Waterbeemd. Review of theoretical passive drug absorption models: historical background, recent developments and limitations.
*Pharm. Acta Helv.***71**:309–327 (1996).PubMedCrossRefGoogle Scholar - 13.K. Palm, K. Luthman, J. Ros, J. Grasjo, and P. Artursson. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.
*J. Pharmacol. Exp. Ther.***291**:435–443 (1999).PubMedGoogle Scholar - 14.K. Obata, K. Sugano, R. Saitoh, A. Higashida, Y. Nabuchi, M. Machida, and Y. Aso. Prediction of oral drug absorption in humans by theoretical passive absorption model.
*Int. J. Pharm.***293**:183–192 (2005).PubMedCrossRefGoogle Scholar - 15.S. Narasimhulu. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
*Biochim. Biophys. Acta***1770**:360–375 (2007).PubMedGoogle Scholar - 16.W. M. Atkins. Non-Michaelis–Menten kinetics in cytochrome P450-catalyzed reactions.
*Annu. Rev. Pharmacol. Toxicol.***45**:291–310 (2005).PubMedCrossRefGoogle Scholar - 17.M. Shou, Y. Lin, P. Lu, C. Tang, Q. Mei, D. Cui, W. Tang, J. S. Ngui, C. C. Lin, R. Singh, B. K. Wong, J. A. Yergey, J. H. Lin, P. G. Pearson, T. A. Baillie, A. D. Rodrigues, and T. H. Rushmore. Enzyme kinetics of cytochrome P450-mediated reactions.
*Current Drug Metabolism***2**:17–36 (2001).PubMedCrossRefGoogle Scholar - 18.K. R. Korzekwa, N. Krishnamachary, M. Shou, A. Ogai, R. A. Parise, A. E. Rettie, F. J. Gonzalez, and T. S. Tracy. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.
*Biochemistry***37**:4137–4147 (1998).PubMedCrossRefGoogle Scholar - 19.G. Camenisch, G. Folkers, and H. van de Waterbeemd. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway.
*Eur. J. Pharm. Sci.***6**:325–329 (1998).PubMedGoogle Scholar - 20.H. Lennernas. Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?
*Pharm. Res.***12**:1573–1582 (1995).PubMedCrossRefGoogle Scholar - 21.P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport.
*Adv. Drug Deliv. Rev.***46**:27–43 (2001).PubMedCrossRefGoogle Scholar - 22.Defense Modeling and Simulation Office, United States Department of Defense.
*Online M&S Glossary*. https://www.dmso.mil/public/resources/glossary/, Cited 3/27/07. Part of the Defense Modeling and Simulation Office Web site, https://www.dmso.mil/public/, Cited 3/27/07. - 23.A. Avdeef. Physicochemical profiling (solubility, permeability and charge state).
*Curr. Top. Med. Chem.***1**:277–351 (2001).PubMedCrossRefGoogle Scholar - 24.A. Barat, H. J. Ruskin, and M. Crane. Probabilistic models for drug dissolution. Part 1. Review of Monte Carlo and stochastic cellular automata approaches.
*Simul. Model. Pract. Theory***14**:843–856 (2006).CrossRefGoogle Scholar - 25.V. Grimm, E. Revilla, U. Berger, F. Jeltsch, W. M. Mooij, S. F. Railsback, H. H. Thulke, J. Weiner, T. Wiegand, and D. L. DeAngelis. Pattern-oriented modeling of agent-based complex systems: lessons from ecology.
*Science***310**:987–991 (2005).PubMedCrossRefGoogle Scholar - 26.B. Faller. Enhancing knowledge through combination of in-silico and
*in-vitro*ADME profiling assays, 1st annual phys. chem. symposium: early ADME and medical chemistry, Obernai, France, (2004). http://www.acdlabs.com/download/publ/2004/eum04/adme.pdf/. Cited 3/27/07. - 27.R. Schulz and D. Winne. Relationship between antipyrine absorption and blood flow rate in rat jejunum, ileum, and colon.
*Naunyn–Schmiedeberg’s Arch. Pharmacol.***335**:97–102 (1987).CrossRefGoogle Scholar - 28.N. Mork, H Bundgaard, M Shalmi, S Christensen. Furosemide prodrugs: synthesis, enzymatic hydrolysis and solubility of various furosemide esters.
*Int. J. Pharm.***60**:163–169 (1990).CrossRefGoogle Scholar - 29.M. R. Grant, K. E. Mostov, T. D. Tlsty, and C. A. Hunt. Simulating properties of
*in vitro*epithelial cell morphogenesis.*PLoS Comput. Biol.***2**:e129 (2006).PubMedCrossRefGoogle Scholar - 30.J. Tang, K. F. Ley, and C. A. Hunt. Dynamics of in silico leukocyte rolling, activation, and adhesion.
*BMC Syst. Biol.***1**:14 (2007).PubMedCrossRefGoogle Scholar - 31.B. P. Zeigler, H. Praehofer, and T. G. Kim.
*Theory of modeling and simulation: integrating discrete event and continuous complex dynamic systems*, Academic, San Diego, 2000.Google Scholar